292 related articles for article (PubMed ID: 9718055)
21. In utero exposure to DES. Evaluation and followup of 199 women.
Fowler WC; Edelman DA
Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
[TBL] [Abstract][Full Text] [Related]
22. Six years' experience with screening of a diethylstilbestrol-exposed population.
Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
[TBL] [Abstract][Full Text] [Related]
23. Cancer Risk in Women Exposed to Diethylstilbestrol in Utero.
Tournaire M; Devouche E; Espié M; Asselain B; Levadou A; Cabau A; Dunbavand A; Grosclaude P; Epelboin S
Therapie; 2015; 70(5):433-41. PubMed ID: 26071143
[TBL] [Abstract][Full Text] [Related]
24. Australia recognises cancer risk for "DES daughters".
Fickling D
Lancet; 2004 Jun; 363(9426):2059. PubMed ID: 15209080
[No Abstract] [Full Text] [Related]
25. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
Barclay DL
J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
[TBL] [Abstract][Full Text] [Related]
26. Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring.
Kaufman RH; Adam E; Hatch EE; Noller K; Herbst AL; Palmer JR; Hoover RN
Obstet Gynecol; 2000 Oct; 96(4):483-9. PubMed ID: 11004345
[TBL] [Abstract][Full Text] [Related]
27. Six cases of women with diethylstilbestrol in utero demonstrating long-term manifestations and current evaluation guidelines.
Tedeschi CA; Rubin M; Krumholz BA
J Low Genit Tract Dis; 2005 Jan; 9(1):11-8. PubMed ID: 15870516
[TBL] [Abstract][Full Text] [Related]
28. Intrauterine exposure to diethylstilbestrol: long-term effects in humans.
Swan SH
APMIS; 2000 Dec; 108(12):793-804. PubMed ID: 11252812
[TBL] [Abstract][Full Text] [Related]
29. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
[TBL] [Abstract][Full Text] [Related]
30. The current status of the DES-exposed population.
Herbst AL
Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
[TBL] [Abstract][Full Text] [Related]
31. Screening for cancers of the cervix and vagina for women exposed to diethylstilbestrol (DES) in utero.
Tournaire M; Devouche E; Lafaye N; Levadou A
J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102042. PubMed ID: 33310134
[TBL] [Abstract][Full Text] [Related]
32. Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughters.
Verloop J; van Leeuwen FE; Helmerhorst TJM; de Kok IMCM; van Erp EJM; van Boven HH; Rookus MA
Gynecol Oncol; 2017 Feb; 144(2):305-311. PubMed ID: 27939984
[TBL] [Abstract][Full Text] [Related]
33. Cancer risk in men exposed in utero to diethylstilbestrol.
Strohsnitter WC; Noller KL; Hoover RN; Robboy SJ; Palmer JR; Titus-Ernstoff L; Kaufman RH; Adam E; Herbst AL; Hatch EE
J Natl Cancer Inst; 2001 Apr; 93(7):545-51. PubMed ID: 11287449
[TBL] [Abstract][Full Text] [Related]
34. Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES).
Titus-Ernstoff L; Troisi R; Hatch EE; Wise LA; Palmer J; Hyer M; Kaufman R; Adam E; Strohsnitter W; Noller K; Herbst AL; Gibson-Chambers J; Hartge P; Hoover RN
Int J Epidemiol; 2006 Aug; 35(4):862-8. PubMed ID: 16723367
[TBL] [Abstract][Full Text] [Related]
35. Management of the adolescent girl exposed in utero to DES.
Gerbie MV
Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
[TBL] [Abstract][Full Text] [Related]
36. Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero.
Mittendorf R
Teratology; 1995 Jun; 51(6):435-45. PubMed ID: 7502243
[TBL] [Abstract][Full Text] [Related]
37. Adverse health outcomes in women exposed in utero to diethylstilbestrol.
Hoover RN; Hyer M; Pfeiffer RM; Adam E; Bond B; Cheville AL; Colton T; Hartge P; Hatch EE; Herbst AL; Karlan BY; Kaufman R; Noller KL; Palmer JR; Robboy SJ; Saal RC; Strohsnitter W; Titus-Ernstoff L; Troisi R
N Engl J Med; 2011 Oct; 365(14):1304-14. PubMed ID: 21991952
[TBL] [Abstract][Full Text] [Related]
38. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
Waggoner SE; Mittendorf R; Biney N; Anderson D; Herbst AL
Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291
[TBL] [Abstract][Full Text] [Related]
39. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol.
Herbst AL; Anderson D
Semin Surg Oncol; 1990; 6(6):343-6. PubMed ID: 2263810
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero.
Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA
Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
